arrow
M

Marco Dioguardi Burgio

Centre de Recherche sur l'Inflammation
H指数:29
被引数:2,532

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Vessels Encapsulating Tumor Clusters predict better outcomes in advanced hepatocellular carcinoma treated with atezolizumab–bevacizumab

包裹肿瘤簇的血管可预测接受阿替利珠单抗–贝伐珠单抗治疗的晚期肝细胞癌的更好预后

2026-04-290
OAAI
ASO Author Reflections: Neoadjuvant Oxaliplatin and Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: CT Features of Chemotherapy-Associated Liver Injury and Postoperative Complications

ASO 作者反思:胰腺导管腺癌的新辅助奥沙利铂治疗与胰十二指肠切除术:化疗相关肝损伤的 CT 特征及术后并发症

2026-04-220
PRE
ASO Visual Abstract: Neoadjuvant Oxaliplatin and Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: CT Features of Chemotherapy-Associated Liver Injury and Postoperative Complications

ASO视觉摘要:胰腺导管腺癌的新辅助奥沙利铂治疗和胰十二指肠切除术:化疗相关肝损伤和术后并发症的CT特征

2026-04-120
PRE
Neoadjuvant Oxaliplatin and Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: CT Features of Chemotherapy-Associated Liver Injury and Postoperative Complications

新辅助奥沙利铂治疗及胰十二指肠切除术治疗胰管腺癌:化疗相关肝损伤的CT特征及术后并发症

2026-04-010
PRE
Prospective Comparison of Attenuation Imaging and Controlled Attenuation Parameter for Liver Steatosis Diagnosis in Patients With Nonalcoholic Fatty Liver Disease and Type 2 Diabetes

衰减成像和受控衰减参数对非酒精性脂肪性肝病和2型糖尿病患者肝脂肪变性诊断的前瞻性比较

2024-05-016
PRE
Ultrasound-based steatosis grading system using 2D-attenuation imaging: An individual patient data meta-analysis with external validation
2024-04-232
PRE
How young radiologists use contrast media and manage adverse reactions: an international survey
2024-03-261
OAAI
Association of LI-RADS and Histopathologic Features with Survival in Patients with Solitary Resected Hepatocellular Carcinoma
RADIOLOGY
IF15.2
2024-02-015
OA